Plasmid-mediated AmpC: Prevalence in community-acquired isolates in Amsterdam, the Netherlands, and risk factors for carriage

PLoS ONE

Volumn 10, Issue 1, 2015, Pages

  Reuland, E Ascelijn ^a   Halaby, Teysir ^b   Hays, John P ^c   De Jongh, Denise M C ^c   Snetselaar, Henrieke D R ^a   Van Keulen, Marte ^a   Elders, Petra J M ^a   Savelkoul, Paul H M ^a   Vandenbroucke Grauls, Christina M J E ^a   Al Naiemi, Nashwan ^a,b,d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Laboratory for Medical Microbiology and Public Health   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d TWENTEBORG HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE AMPC; BETA LACTAMASE CTX M; RNA 16S; AMPC BETA-LACTAMASES; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME;

ADULT; AGED; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLACTX GENE; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NETHERLANDS; NONHUMAN; PLASMID; REPLICON; RISK FACTOR; VERY ELDERLY; ADOLESCENT; ANTIBIOTIC RESISTANCE; CHEMISTRY; FECES; GENETICS; MICROBIAL SENSITIVITY TEST; MIDDLE AGED; YOUNG ADULT;

NEGIBACTERIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CEFOTAXIME; CEFTAZIDIME; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FECES; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 84920971263     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113033     Document Type: Article

References (38)

1. Jacoby GA (2009) AmpC beta-lactamases. Clin Microbiol Rev 22: 161-182, Table of Contents. doi: 10.1128/CMR.00036-08 PMID: 19136439
2. Rodriguez-Bano J, Miro E, Villar M, Coelho A, Gozalo M, et al. (2012) Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC beta-lactamases. J Infect 64: 176-183. doi: 10.1016/j.jinf.2011.11.016 PMID: 22138600
3. Philippon A, Arlet G, Jacoby GA (2002) Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Chemother 46: 1-11. doi: 10.1128/AAC.46.1.1-11.2002 PMID: 11751104
4. Nadjar D, Rouveau M, Verdet C, Donay L, Herrmann J, et al. (2000) Outbreak of Klebsiella pneumoniae producing transferable AmpC-type beta-lactamase (ACC-1) originating from Hafnia alvei. FEMS Microbiol Lett 187: 35-40. doi: 10.1016/S0378-1097(00)00166-X PMID: 10828397
5. Ohana S, Leflon V, Ronco E, Rottman M, Guillemot D, et al. (2005) Spread of a Klebsiella pneumoniae strain producing a plasmid-mediated ACC-1 AmpC beta-lactamase in a teaching hospital admitting disabled patients. Antimicrob Agents Chemother 49: 2095-2097. doi: 10.1128/AAC.49.5.2095-2097. 2005 PMID: 15855536
6. Ktari S, Arlet G, Verdet C, Jaoua S, Kachrid A, et al. (2009) Molecular epidemiology and genetic environment of acquired bla ACC-1 in Salmonella enterica serotype Livingstone causing a large nosocomial outbreak in Tunisia. Microb Drug Resist 15: 279-286. doi: 10.1089/mdr.2009.0035 PMID: 19857134
7. Roh KH, Uh Y, Kim JS, Kim HS, Shin DH, et al. (2008) First outbreak of multidrug-resistant Klebsiella pneumoniae producing both SHV-12-type extended-spectrum beta-lactamase and DHA-1-type AmpC beta-lactamase at a Korean hospital. Yonsei Med J 49: 53-57. doi: 10.3349/ymj.2008.49.1.53 PMID: 18306469
8. Huang IF, Chiu CH, Wang MH, Wu CY, Hsieh KS, et al. (2005) Outbreak of dysentery associated with ceftriaxone-resistant Shigella sonnei: First report of plasmid-mediated CMY-2-type AmpC betalactamase resistance in S. sonnei. J Clin Microbiol 43: 2608-2612. doi: 10.1128/JCM.43.6.2608-2612.2005 PMID: 15956372
9. al Naiemi N, Cohen Stuart J, Leverstein van Hall M (2008) NVMM guideline of the Dutch Society for Medical Microbiology for screening and confirmation of extended-spectrum beta-lactamases (ESBLs) in Enterobacteriaceae [in Dutch]. NVMM website. Available: http://www.nvmm.nl/richtlijnen/esbl. Accessed 2011 Jul 1.
10. Cohen Stuart J, Leverstein-Van Hall MA (2010) Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteriaceae. Int J Antimicrob Agents 36: 205-210. doi: 10.1016/j.ijantimicag.2010.05.014 PMID: 20598859
11. EUCAST European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters Version 20, valid from 2012-01-01 Växjö: EUCAST Available: http://wwweucastorg/fileadmin/src/media/PDFs/EUCAST-files/Breakpoint-tables/Breakpoint-table-v-20pdf. Accessed 2012 Nov 1.
12. Tan TY, Ng LS, He J, Koh TH, Hsu LY (2009) Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Antimicrob Agents Chemother 53: 146-149. doi: 10.1128/AAC.00862-08 PMID: 18955528
13. Reuland EA, Hays JP, de Jongh DM, Abdelrehim E, Willemsen I, et al. (2014) Detection and occurrence of plasmid-mediated AmpC in highly resistant gram-negative rods. PLoS One 9: e91396. doi: 10.1371/journal.pone.0091396 PMID: 24642853
14. Perez-Perez FJ, Hanson ND (2002) Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40: 2153-2162. doi: 10.1128/JCM.40.6.2153-2162.2002 PMID: 12037080
15. Cuzon G, Naas T, Bogaerts P, Glupczynski Y, Nordmann P (2012) Evaluation of a DNA microarray for the rapid detection of extended-spectrum beta-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM). J Antimicrob Chemother 67: 1865-1869. PMID: 22604450
16. Naiemi NA, Duim B, Savelkoul PH, Spanjaard L, de Jonge E, et al. (2005) Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology. J Clin Microbiol 43: 4862-4864. doi: 10.1128/JCM.43.9.4862-4864.2005 PMID: 16145160
17. Mulvey MR, Bryce E, Boyd DA, Ofner-Agostini M, Land AM, et al. (2005) Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob Agents Chemother 49: 358-365. doi: 10.1128/AAC.49.1.358-365.2005 PMID: 15616316
18. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, et al. (2005) Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 63: 219-228. doi: 10.1016/j.mimet.2005.03.018 PMID: 15935499
19. Savelkoul PH, Aarts HJ, de Haas J, Dijkshoorn L, Duim B, et al. (1999) Amplified-fragment length polymorphism analysis: the state of an art. J Clin Microbiol 37: 3083-3091. PMID: 10488158
20. Endimiani A, Hujer AM, Hujer KM, Gatta JA, Schriver AC, et al. (2010) Evaluation of a commercial microarray system for detection of SHV-, TEM-, CTX-M-, and KPC-type beta-lactamase genes in Gramnegative isolates. J Clin Microbiol 48: 2618-2622. doi: 10.1128/JCM.00568-10 PMID: 20504993
21. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, et al. (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18: 268-281. doi: 10.1111/j.1469-0691.2011.03570.x PMID: 21793988
22. Borjesson S, Jernberg C, Brolund A, Edquist P, Finn M, et al. (2013) Characterization of plasmid-mediated AmpC-producing E. coli from Swedish broilers and association with human clinical isolates. Clin Microbiol Infect 19: E309-311. doi: 10.1111/1469-0691.12192 PMID: 23581796
23. Bortolaia V, Hansen KH, Nielsen CA, Fritsche TR, Guardabassi L (2014) High diversity of plasmids harbouring blaCMY-2 among clinical Escherichia coli isolates from humans and companion animals in the upper Midwestern USA. J Antimicrob Chemother 69: 1492-1496. doi: 10.1093/jac/dku011 PMID: 24500191
24. Cejas D, Fernandez Canigia L, Quinteros M, Giovanakis M, Vay C, et al. (2012) Plasmid-Encoded AmpC (pAmpC) in Enterobacteriaceae: epidemiology of microorganisms and resistance markers. Rev Argent Microbiol 44: 182-186. PMID: 23102467
25. Corvec S, Cremet L, Leprince C, Dauvergne S, Reynaud A, et al. (2010) Epidemiology of Escherichia coli clinical isolates producing AmpC plasmidic beta-lactamase during a 5-year period in a French teaching Hospital. Diagn Microbiol Infect Dis 67: 277-281. doi: 10.1016/j.diagmicrobio.2010.02.007 PMID: 20462724
26. Voets GM, Platteel TN, Fluit AC, Scharringa J, Schapendonk CM, et al. (2012) Population distribution of Beta-lactamase conferring resistance to third-generation cephalosporins in human clinical Enterobacteriaceae in the Netherlands. PLoS One 7: e52102. doi: 10.1371/journal.pone.0052102 PMID: 23284886
27. Ahmed SF, Ali MM, Mohamed ZK, Moussa TA, Klena JD (2014) Fecal carriage of extended-spectrum beta-lactamases and AmpC-producing Escherichia coli in a Libyan community. Ann Clin Microbiol Antimicrob 13: 22. doi: 10.1186/1476-0711-13-22 PMID: 24934873
28. Garrido A, Seral C, Gude MJ, Casado C, Gonzalez-Dominguez M, et al. (2014) Characterization of Plasmid-Mediated beta-Lactamases in Fecal Colonizing Patients in the Hospital and Community Setting in Spain. Microb Drug Resist 20: 301-304. doi: 10.1089/mdr.2013.0109 PMID: 24328895
29. Lee CH, Lee YT, Kung CH, Ku WW, Kuo SC, et al. (2013) Risk factors of community-onset urinary tract infections caused by plasmid-mediated AmpC beta-lactamase-producing Enterobacteriaceae. J Microbiol Immunol Infect. doi: 10.1016/j.jmii.2013.08.010
30. Pitout JD, Gregson DB, Church DL, Laupland KB (2007) Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary. Emerg Infect Dis 13: 443-448. doi: 10. 3201/eid1303.060447 PMID: 17552098
31. Hanson ND, Moland ES, Hong SG, Propst K, Novak DJ, et al. (2008) Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 beta-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community. Antimicrob Agents Chemother 52: 3814-3816. doi: 10.1128/AAC.00877-08
32. Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, et al. (1999) Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 281: 517-523. doi: 10.1001/jama.281.6.517 PMID: 10022107
33. Reuland EA, Overdevest IT, Al Naiemi N, Kalpoe JS, Rijnsburger MC, et al. (2012) High prevalence of ESBL-producing Enterobacteriaceae carriage in Dutch community patients with gastrointestinal complaints. Clin Microbiol Infect.
34. Pitout JD, Nordmann P, Laupland KB, Poirel L (2005) Emergence of Enterobacteriaceae producing extended- spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 56: 52-59. doi: 10.1093/jac/dki166 PMID: 15917288
35. Woodford N, Reddy S, Fagan EJ, Hill RL, Hopkins KL, et al. (2007) Wide geographic spread of diverse acquired AmpC beta-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland. J Antimicrob Chemother 59: 102-105. doi: 10.1093/jac/dkl456 PMID: 17110393
36. Jacoby GA, Munoz-Price LS (2005) The new beta-lactamases. N Engl J Med 352: 380-391. doi: 10.1056/NEJMra041359 PMID: 15673804
37. Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B, et al. (2007) Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 51: 1987-1994. doi: 10.1128/AAC.01509-06 PMID: 17387156
38. Naseer U, Haldorsen B, Simonsen GS, Sundsfjord A (2010) Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway. Clin Microbiol Infect 16: 171-178. doi: 10.1111/j.1469-0691.2009.02861.x PMID: 19548922